Treatment of steroid-resistant systemic lupus erythematosus with extremely low dose of cyclosporine A
β Scribed by Takashi Sakano; Toshiyuki Ohta; Yoshihisa Kinoshita; Mami Fjiwara; Mari Wakai
- Book ID
- 108970852
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 139 KB
- Volume
- 46
- Category
- Article
- ISSN
- 1328-8067
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. To determine the effect of low-dose cyclosporin A (CSA) treatment on disease activity in systemic lupus erythematosus (SLE). Methods. All patients in the study had active disease as defined by at least the presence of a low CH50 level. Patients were initially given 3 mg/kg/day of CSA. Do
Objective. To evaluate the efficacy of long-term treatment with cyclosporin A (CSA) in systemic lupus erythematosus (SLE). Methods. Thirty patients with SLE whose condition was either poorly responsive or unresponsive to treatment with steroids and/or cytotoxic drugs were enrolled in a prospective,